Transgenerational Transmission of Reproductive and Metabolic Dysfunction in Male Progeny of Polycystic Ovary Syndrome

    May 2023 in “ Cell reports medicine ”
    Sanjiv Risal, Congru Li, Qing Luo, Romina Fornes, Haojiang Lu, Gustaw Eriksson, Maria Manti, Claes Ohlsson, Eva Lindgren, Nicolás Crisosto, Manuel Maliqueo, Bárbara Echiburú, Sergio E Recabarren, Teresa Sir Petermann, Anna Benrick, Nele Brusselaers, Jie Qiao, Qiaolin Deng, Elisabet Stener-Victorin
    Image of study
    TLDR Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.
    The study "Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome" examined the effects of maternal polycystic ovary syndrome (PCOS) on male offspring. The research involved 467,275 sons born in Sweden between July 2006 and December 2015, of which 9,828 (2.10%) were born to mothers diagnosed with PCOS. The study found that these sons had a higher risk of obesity and altered lipid profiles, indicating insulin resistance. The study also identified potential microRNAs (miRNAs) that could contribute to the transmission of PCOS traits in humans. These miRNAs are involved in pathways related to insulin resistance, sex differentiation, and hormone response. The study also found that these miRNAs appear to regulate six PCOS-risk genes. The findings suggest that sons of women with PCOS may carry circulating factors that increase their susceptibility to developing PCOS traits. The study also found that maternal PCOS could induce fetal programming, predisposing not only daughters but also sons to adult disease due to an adverse maternal-fetal environment. The study strengthens the hypothesis that maternal PCOS can have transgenerational effects.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 12 results

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 11 months ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 month ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 11 months ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 4 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results